mick Saturday, 05/18/19 05:02:26 PM Re: mick post# 44523 Post # of 46048 So demand for opioids is already dwindling. But on top of that, price transparency will up the competition between prescription drugs, which busts the door wide open for medical marijuana as well. A study from the National Center for Biology Information said 97% of medical cannabis patients were able to decrease their opiate usage when they could also use cannabis, and 81% strongly agreed that cannabis was more effective on its own than alongside opioids. A more competitive drug market only reinforces that 2019 is a big year for marijuana stocks, as legal barriers are dissolved between marijuana and people suffering from chronic pain. So far, 33 states and Washington, D.C., have legalized medical marijuana. It's happened right as consumers' sights are drifting toward alternatives for pain relief, and while pharmaceutical companies are at their most vulnerable. Increased competition will spark the emergence of better and cheaper drugs, and it will give Medicare and Medicaid the ability to better negotiate the prices they pay.